Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Equillium Inc EQ

Healthcare Biotechnology

Equillium, Inc. is a clinical-stage biotechnology company. It is engaged in developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The Company’s pipeline consists of immunomodulatory assets and a product platform targeting immuno-inflammatory pathways. The Company’s EQ101 is a selective tri-specific cytokine inhibitor targeting IL-2, IL... see more

Add To Watchlist

Bullboard (NDAQ:EQ)

View:

Post by whytestockson Jun 04, 2024 7:15pm

Equillium Announces Positive Topline Data from Phase 2 Study

News; $EQ Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata20% of all subjects that completed the 24-week treatment period achieved SALT @ 20 29% of completed ...more

38

Post by Shanemorg58on Dec 06, 2022 1:44pm

Strong Hold!

HUGE news! New partnership with Ono, a leading Japanese pharmaceutical company to further itolizumab!! the potential of itolizumab is going to be big. Check out this link: https://ca.finance.yahoo.com ...more

114

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by JohnTool321on Aug 05, 2022 7:58pm

RE:RE:Bang zoom

101

Discussion

Comment by SusanBollandon Jul 11, 2022 5:53am

RE:RE:Bang zoom

59

Discussion

Comment by Lisagerrard17on Jul 08, 2022 8:57am

RE:RE:Bang zoom

58

Discussion

Comment by Joe455on May 30, 2022 12:35pm

RE:RE:Bang zoom

Those T cells can be tricky.

116

Discussion

Comment by GassXXon May 29, 2022 5:13am

RE:Bang zoom

117

Discussion

Post by happerdanon Jul 13, 2020 3:33pm

Bang zoom

To the moon!

163

Discussion

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities